Figure 3: Echocardiographic and Neurohormonal Parameters

Serial changes in (A) left ventricular (LV) end-diastolic and -systolic diameter; (B) LV ejection fraction; and serum levels of (C) brain natriuretic peptide and (D) peripheral blood norepinephrine at baseline, post-MI, after MI + HF, and at 10-week follow-up in the control group (n = 10) and RD group (n = 10). (E) Changes in the venoarterial gradients of norepinephrine over the myocardium and left and right kidney during MI + HF and at 10-week follow-up in the control group (n = 10) and RD group (n = 10). Serial changes in serum levels of (F) angiotensin II and (G) creatinine at baseline, post-MI, after MI + HF, and at 10-week follow-up in the control group (n = 10) and RD group (n = 10). Abbreviations as in Figure 2.